AstraZeneca tests diabetes drug for COVID-19 despite risk seen by doctors
The trial of 900 hospitalized patients, dubbed DARE-19, will test Farxiga against a placebo with results expected by December. The international study began in April.
The logo of AstraZeneca is seen on a medication package in a pharmacy in London April 28, 2014(photo credit: STEFAN WERMUTH/REUTERS)ByREUTERS
